INVIVO MODIFICATION OF DELAYED-TYPE HYPERSENSITIVITY BY SMALL MOLECULAR-WEIGHT COMPONENTS DERIVED FROM HUMAN-LEUKOCYTES - PARTIAL-PURIFICATION OF COMPONENTS CAUSING AMPLIFICATION OF RESPONSE
- 1 January 1982
- journal article
- research article
- Vol. 50 (2) , 434-441
Abstract
Human leukocyte dialysates contain components which, when injected intradermally in combination with an antigen to which the recipient displays prior sensitivity, produces an accelerated and intensified delayed hypersensitivity response. These components which were termed leukocyte amplifiers, can be partially purified by gel filtration on Sephadex G-10 followed by high pressure reverse phase chromatography. The amplifiers do not produce an inflammatory reaction when injected intradermally by themselves. Amplifying effects were not observed when analogous sub-fractions prepared from erythrocytes or platelets were employed in the same manner. The leukocyte amplifiers were not able to transfer a new sensitivity to a non-sensitive recipient.This publication has 9 references indexed in Scilit:
- The effects of dialyzable products from human leukocyte extracts on cutaneous delayed-hypersensitivity response.The Journal of Immunology, 1980
- Human Transfer Factor: Structural Properties Suggested by HPRP Chromatography and Enzymatic SensitivitiesThe Journal of Immunology, 1979
- Transfer of delayed cutaneous hypersensitivity with transfer factorCellular Immunology, 1978
- Human transfer factor activity in the guinea pig: Absence of antigen specificityClinical Immunology and Immunopathology, 1977
- Biochemical analysis of dialyzable leukocyte extracts.1977
- Transfer factor in cellular immunity.1974
- Fluorometric assay of proteins in the nanogram rangeArchives of Biochemistry and Biophysics, 1973
- ROLE OF ENDOTOXIN IN EXTRACELLULAR COAGULATION OF LIMULUS BLOOD1964
- THE TRANSFER IN HUMANS OF DELAYED SKIN SENSITIVITY TO STREPTOCOCCAL M SUBSTANCE AND TO TUBERCULIN WITH DISRUPTED LEUCOCYTES 12Journal of Clinical Investigation, 1955